Huidagene
1 known investors
HuidaGene Therapeutics is a gene therapy company developing CRISPR-based treatments across R&D pipelines targeting neurology, ophthalmology, and neuromuscular diseases, including MECP2 Duplication Syndrome, Huntington's Disease, ALS, and inherited retinal dystrophies. Its programs include first-in-human clinical trials for genetic disorders.
Investors · 1
Frequently asked questions
- What does Huidagene do?
- HuidaGene Therapeutics is a gene therapy company developing CRISPR-based treatments across R&D pipelines targeting neurology, ophthalmology, and neuromuscular diseases, including MECP2 Duplication Syndrome, Huntington's Disease, ALS, and inherited retinal dystrophies. Its programs include first-in-human clinical trials for genetic disorders.
- Who are Huidagene's investors?
- Huidagene's investors include HM Venture Partners.